Sector footprint
$25.6K in exports
Reported chemicals exports in 2024 across 11 qualifying HS6 products.
Sector export playbook ยท HS 28-38
Palau Chemicals exports
where capability meets demand
Explore Palau's HS 28-38 product portfolio, buyer markets, growth signals, and diversification opportunities. Use this guide to prioritize research, not to treat calculated indicators as guaranteed sales.
Sector exports$25.6K2024 reported value
Products11Qualifying HS6 products
Buyer markets6Markets represented
Average CAGR-23.9%Product-level growth signal
Global sector size$15.9BReported buyer imports
Chemicals capability
How strong is Palau in this sector?
Compare exporter scale with product breadth, buyer demand, growth, and destination reach. A large sector does not remove the need for product, compliance, pricing, and buyer validation.
Global demand
$15.9B buyer imports
The sector's reported buyer import base provides context for product and market prioritization.
How to use the guide
Find the next credible move
Start with products that combine demand and exporter capability, then validate standards, route economics, buyers, and competition.
Product portfolio
Which products anchor the sector?
Each HS6 product is ranked by calculated opportunity and shown with reported market size, exporter exports, growth, and destination reach.
| Product | Global size | Your exports | Opportunity | CAGR | Markets | Share |
|---|---|---|---|---|---|---|
| HS 300490Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $12.4B | $10.9K | $3.8B | -37.2% | 3 | +0.0% |
| HS 300439Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | $1.8B | $293.9 | $556.4M | -32.9% | 1 | +0.0% |
| HS 293499Nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934 | $386.8M | $35.8 | $209.3M | +16.9% | 1 | +0.0% |
| HS 300390Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | $382.9M | $61.7 | $153.1M | -53.2% | 1 | +0.0% |
| HS 300590Wadding, gauze, bandages and similar articles: (excluding adhesive dressings), impregnated or coated with pharmaceutical substances, packaged for retail sale | $117.6M | $10.1 | $90.4M | -35.1% | 1 | +0.0% |
| HS 330430Cosmetic and toilet preparations: manicure or pedicure preparations | $152.1M | $1.9 | $76.3M | -19.6% | 1 | +0.0% |
| HS 350691Adhesives: prepared, based on polymers of heading 3901 to 3913 or on rubber | $151.4M | $1.9 | $59.1M | +3.6% | 1 | +0.0% |
| HS 300420Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | $285.5M | $6.2 | $48.0M | -29.6% | 1 | +0.0% |
| HS 350699Glues and other adhesives: prepared, n.e.s. in heading no. 3506, not exceeding a net weight of 1kg | $83.5M | $1.3 | $44.5M | -3.6% | 1 | +0.0% |
| HS 330300Perfumes and toilet waters | $64.9M | $14.3K | $23.6M | -7.3% | 1 | +0.0% |
| HS 340600Candles, tapers and the like | $32.1M | $16.3 | $11.3M | -38.1% | 1 | +0.0% |
Best markets
Where does sector demand concentrate?
Markets are ranked by calculated opportunity across the qualifying products in this sector view.
JPN
Japan
6 products represented in the sector.
$4.5B$14.4B reported buyer importsKOR
Republic of Korea
1 products represented in the sector.
$209.3M$386.8M reported buyer importsTWN
Taiwan
2 products represented in the sector.
$103.7M$234.8M reported buyer importsCRI
Costa Rica
1 products represented in the sector.
$81.7M$413.9M reported buyer importsUSA
USA, Puerto Rico and US Virgin Islands
1 products represented in the sector.
$76.3M$152.1M reported buyer importsWXD
World excl. Intra-EU
2 products represented in the sector.
$66.6M$261.3M reported buyer importsGrowth stars
Which products show the strongest growth?
Average product-level CAGR is a screening signal. Confirm the latest trend, base effects, buyer quality, and commercial feasibility before acting.
| Product | Average CAGR | Opportunity | Markets |
|---|---|---|---|
| HS 293499Nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934 | +16.9% | $209.3M | 1 |
| HS 350691Adhesives: prepared, based on polymers of heading 3901 to 3913 or on rubber | +3.6% | $59.1M | 1 |
| HS 350699Glues and other adhesives: prepared, n.e.s. in heading no. 3506, not exceeding a net weight of 1kg | -3.6% | $44.5M | 1 |
| HS 330300Perfumes and toilet waters | -7.3% | $23.6M | 1 |
| HS 330430Cosmetic and toilet preparations: manicure or pedicure preparations | -19.6% | $76.3M | 1 |
| HS 300420Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | -29.6% | $48.0M | 1 |
| HS 300439Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | -32.9% | $556.4M | 1 |
| HS 300590Wadding, gauze, bandages and similar articles: (excluding adhesive dressings), impregnated or coated with pharmaceutical substances, packaged for retail sale | -35.1% | $90.4M | 1 |
| HS 300490Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | -37.2% | $3.8B | 3 |
| HS 340600Candles, tapers and the like | -38.1% | $11.3M | 1 |
Diversification opportunities
Which products reach the widest buyer base?
Destination count is a simple breadth indicator. It does not measure destination concentration or guarantee resilience.
HS 300490
Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale
3 markets$3.8B calculated opportunityHS 300439
Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale
1 markets$556.4M calculated opportunityHS 293499
Nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934
1 markets$209.3M calculated opportunityHS 300390
Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale)
1 markets$153.1M calculated opportunityHS 300590
Wadding, gauze, bandages and similar articles: (excluding adhesive dressings), impregnated or coated with pharmaceutical substances, packaged for retail sale
1 markets$90.4M calculated opportunityHS 330430
Cosmetic and toilet preparations: manicure or pedicure preparations
1 markets$76.3M calculated opportunityHS 350691
Adhesives: prepared, based on polymers of heading 3901 to 3913 or on rubber
1 markets$59.1M calculated opportunityHS 300420
Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale
1 markets$48.0M calculated opportunityFrequently asked questions
Using the Chemicals export playbook
Practical guidance for interpreting sector scale, growth, product breadth, and buyer markets.
How strong is Palau in this sector?
Compare sector exports, product breadth, buyer markets, growth, and global demand. These signals identify research priorities rather than guarantee market access.
What are growth stars?
Products with higher average reported growth in the screened rows. Validate the time period, base effects, buyer demand, and current exporter position.
What does diversification mean here?
Products reaching more buyer markets in the screened data. Destination breadth is useful context but does not replace concentration, route, or buyer analysis.
Data source
OECD trade statistics with CEPII context
OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). OECD BIMTS is the primary trade series for this view. Supporting bilateral trade context uses CEPII BACI bilateral trade flows (202601) under Etalab 2.0 Open Licence. Yugalinks presents derived views of reported observations and calculated indicators. Data terms: OECD Terms & Conditions.